4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-18-000554
Director sold 920 shares at $12.51 ($11,509)
- Director acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-05 | Option exercise : show line 1 in the form | −2,000 | $5.75 | $11,500 | 19,236 | I |
| 2018-06-05 | Sale : show line 2 in the form | −920 | $12.51 | $11,509 | 18,316 | I |
| Open-market sales · 920 sh · avg $12.51 · $11,509 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-06-05 | Option exercise : show line 3 in the form Warrant (right to buy) | −2,000 | 0 | I |
Loading xslF345X03/crispr-fm4_jun42018.xml…